A-1331852: Mechanism of Action

A-1331852 MOA:Targeting BCL-XL/Apoptosis Pathway for Oncology

🎯 check A-1331852 product page

A-1331852 is a potent, selective Bcl-xL inhibitor. It affects the apoptosis signaling pathway by disrupting Bcl-xL/BIM complexes and promoting BAX/BAK activation, effectively inducing apoptosis and inhibiting tumor growth and fibrosis.

Primary Applications and Mechanism of Action